Long-term effects of low calcium dialysates on the serum calcium levels during maintenance hemodialysis treatments: A systematic review and meta-analysis

Hypercalcemia and hyperparathyroidism in patients receiving maintenance hemodialysis (MHD) can cause the progression of cardiovascular diseases (CVD) and mineral bone disorders (MBD). The KDIGO recommends the dialysates with a calcium (Ca) concentration of 1.25–1.5 mmol/L for MHD treatments, but the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshikawa, Masahiro, Takase, Osamu, Tsujimura, Taro, Sano, Etsuko, Hayashi, Matsuhiko, Takato, Tsuyoshi, Hishikawa, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871761/
https://www.ncbi.nlm.nih.gov/pubmed/29593281
http://dx.doi.org/10.1038/s41598-018-23658-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871761/
https://www.ncbi.nlm.nih.gov/pubmed/29593281
http://dx.doi.org/10.1038/s41598-018-23658-y

Ejemplares similares